D-0521-2025 Class II Ongoing
FDA drug recall D-0521-2025 was initiated by ACCORD HEALTHCARE, INC. on Jun 20, 2025 and is designated Class II. Reason for recall: Subpotent Drug: Assay below the approved specification The recall status is ongoing. Affected quantity: 9,739 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 23, 2025
- Initiation Date
- Jun 20, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9,739 bottles
Product description
Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-451-17
Reason for recall
Subpotent Drug: Assay below the approved specification
Distribution pattern
Nationwide in the USA
Code information
Lot #D2300092, Exp Date: 12/31/2025; Lot #D2400722, Exp Date: 03/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0521-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026